Sumeet AsraniBaylor Univ., USA

Session: KASL-AASLD Joint Symposium 1. Randomized Controlled Trials in Hepatology

Lecture: Practical Tips for Designing and Conducting Successful RCT

Session: KASL Symposium 4. Integrative Approaches to Alcohol-Related Hepatic Disorders

Lecture: Emerging Regimens Competing with Glucocorticoids for Severe Alcoholic Hepatitis

Chien-Hung ChenNational Taiwan Univ., Taiwan

Session: TLW Special Interest Group. Integrating Multi-Omics for Precision Oncology [Chairperson]

Session: KLCA-TLCA Joint Symposium. Innovating and Expanding Surgical Horizons for Hepatocellular Carcinoma in the Immunotherapy Era

Lecture: Immune Checkpoint Inhibitors and Biomarker Discovery: Tailoring Treatment for HCC

Valerie ChewDuke-NUS Medical School, Singapore

Session: TLW Special Interest Group. Integrating Multi-Omics for Precision Oncology

Lecture: Immune Microenvironment and Therapeutic Discovery in HCC Using Single-Cell Omics Analysis

Markus CornbergHannover Medical School, Germany

Session: KASL Symposium 2. The Immunological Horizon Towards Curing Viral Hepatitis and Beyond

Lecture: Targeting Adaptive Immunity as a Promising Approaches for Curing Hepatitis B

Renumathy DhanasekaranStanford Univ., USA

Session: TLW Special Interest Group. Integrating Multi-Omics for Precision Oncology

Lecture: Molecular Insights into HCC Recurrence from Minimal Residual Disease after Therapy

Session: KASL-AASLD Joint Symposium 2. Looking into the Future of Hepatology

Lecture: Molecular and Immunological Biomarkers for Hepatocellular Carcinoma to Guide Personalized Treatment Decisions

Jacob GeorgeThe Univ. of Sydney, Australia

Session: KLCA Symposium 3. Revisiting and Expanding Hepatocellular Carcinoma Treatment Paradigms: From Standard to Innovative Therapies

Lecture: The Emerging Role of Immuno-Oncology Therapy in Neo- and Adjuvant Treatment for HCC

Etsuro HatanoKyoto Univ., Japan

Session: KAHBPS Symposium 1. Assessment and Management of Uncommon Considerations in Liver Surgery

Lecture: Elderly Patients Over 75 Years

Session: KLCA-JLCA Joint Symposium. Optimizing Bridging Gaps in Pre- and Post-Liver Transplantation Management for Hepatocellular Carcinoma [Chairperson]

Shang-Chin HuangNational Taiwan Univ., Taiwan

Session: KASL Special Interest Group 1. The KASL Steatotic Liver Disease Study Group

Lecture: Relationship between MASLD and Chronic Hepatitis B: Friends or Foes

Yi-Hsiang HuangNational Yang Ming Chiao Tung Univ., Taiwan

Session: KLCA Symposium 3. Revisiting and Expanding Hepatocellular Carcinoma Treatment Paradigms: From Standard to Innovative Therapies

Lecture: Systemic Therapy and Transarterial Chemoembolization in BCLC Intermediate Stage: A Survival Boost?

Session: KLCA-TLCA Joint Symposium. Innovating and Expanding Surgical Horizons for Hepatocellular Carcinoma in the Immunotherapy Era [Chairperson]

Hideki IwamotoKurume Univ., Japan

Session: KLCA Symposium 2. Advancing Biomarker Discovery and Translational Insights in Liver Cancer

Lecture: Targeting Tumor Microenvironment Biomarkers: Implications for Novel Therapies

Chinburen JigjidsurenNational Cancer Center, Mongolia

Session: KAHBPS Symposium 1. Assessment and Management of Uncommon Considerations in Liver Surgery (Chairperson)

Tatsuya KantoNational Center for Global Health and Medicine, Japan

Session: KASL Symposium 2. The Immunological Horizon Towards Curing Viral Hepatitis and Beyond

Lecture: Development of a Novel Immune Modulator SA-5 as a Therapeutic Option for Chronic Hepatitis B

Session: KASL Symposium 3. Emerging Concepts, Challenges, and Therapeutic Frontiers of Metabolic Dysfunction–Associated Steatotic Liver Disease [Chairperson]

W. Ray KimMayo Clinic, USA

Session: KASL-AASLD Joint Symposium 1. Randomized Controlled Trials in Hepatology [Chairperson]

Session: KASL-AASLD Joint Symposium 2. Looking into the Future of Hepatology

Lecture: Future Directions in Liver Transplant Allocation Policies: Beyond MELD

Kris KowdleyLiver Institute Northwest, USA

Session: KASL-AASLD Joint Symposium 1. Randomized Controlled Trials in Hepatology

Lecture: Successes and Failures in RCT: Insights from AASLD Experiences

Session: KASL Symposium 3. Emerging Concepts, Challenges, and Therapeutic Frontiers of MASLD

Lecture: Resmetirom's Promise and the Challenges Ahead

Chun-Jen LiuNational Taiwan Univ., Taiwan

Session: State-of-the-Art Lecture

Lecture: HBV with Co-Existing Liver Diseases: The Interactions between Viral Hepatitis C, MAFLD, and HBV

Session: KASL Symposium 2. The Immunological Horizon Towards Curing Viral Hepatitis and Beyond [Chairperson]

Loey Lung-Yi MakThe Univ. of Hong Kong, Hong Kong

Session: KASL Symposium 2. The Immunological Horizon Towards Curing Viral Hepatitis and Beyond

Lecture: Targeting Innate Immunity as a Promising Approaches for Curing Hepatitis B

Masao OmataThe Univ. of Tokyo, Japan

Session: State-of-the-Art Lecture (Chairperson)

Munkhbat RadnaabazarNational Cancer Center, Mongolia

Session: KAHBPS Symposium 1. Assessment and Management of Uncommon Considerations in Liver Surgery

Lecture: High-Grade Morbid Obesity

Session: KLTS Symposium 2. Technical Hurdles in Living Donor Liver Transplantation [Chairperson]

Shiv Kumar SarinInstitute of Liver and Biliary Sciences, India

Session: President's Choice Lecture

Lecture: Management of Portal Hypertension in Advanced Cirrhosis

Shashwat SarinMahatma Gandhi Hospital and Univ., India

Session: KASL Symposium 4. Integrative Approaches to Alcohol-Related Hepatic Disorders

Lecture: Specific Management of Portal Hypertension Before and After Liver Transplantation

Poowanai SarkhampeeSunpasitthiprasong Hospital, Thailand

Session: KAHBPS Symposium 2. Laparoscopic Liver Resection vs. Robotic Liver Resection [Chairperson]

Session: KAHBPS Symposium 3. Recent Updates in Cholangiocarcinoma

Lecture: Extent of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma

Barjesh Chander SharmaGovind Ballabh Pant Hospital, India

Session: KASL Symposium 1. Innovative Strategies in Cirrhosis Care [Chairperson]

Session: KASL Symposium 4. Integrative Approaches to Alcohol-Related Hepatic Disorders

Lecture: Altered Mental Status in Alcoholic Cirrhosis: Etiologies Other Than Hepatic Encephalopathy

Manoj Kumar SharmaInstitute of Liver and Biliary Sciences, India

Session: KASL Symposium 1. Innovative Strategies in Cirrhosis Care

Lecture: Primary Hemostasis in Cirrhosis: A Modern Perspective on Coagulopathy

Masahito ShimizuGifu Univ., Japan

Session: KASL Special Interest Group 5. The KASL Study Group of Portal Hypertension

Lecture: Optimizing Nutrition in Cirrhosis: Recent Advances and Clinical Implications

Amit SingalUT Southwestern Medical Center, USA

Session: KAHBPS Symposium 3. Recent Updates in Cholangiocarcinoma

Lecture: Role of Liver Transplantation in the Treatment of Intrahepatic Cholangiocarcinoma

Silvia C. SookoianMaimonides Univ., Argentina

Session: KASL-AASLD Joint Symposium 2. Looking into the Future of Hepatology [Chairperson]

Session: KASL Symposium 3. Emerging Concepts, Challenges, and Therapeutic Frontiers of MASLD

Lecture: New Drug Discovery Based on Multi-Omics

Atsushi TanakaTeikyo Univ., Japan

Session: KASL Special Interest Group 3. The KASL Autoimmune and Rare Liver Disease Study Group

Lecture: Current Status and Research Trends of Autoimmune Liver Diseases in Japan

Shuji TeraiNiigata Univ., Japan

Session: KASL Special Interest Group 6. The KASL Alcohol-Related Problem Study Group

Lecture: Diagnosis and Treatment of Liver Disease Using Extracellular Vesicles

Dominique ThabutSorbonne Univ., France

Session: KASL Symposium 1. Innovative Strategies in Cirrhosis Care

Lecture: Treatment of Portal Hypertension in Patients with Hepatocellular Carcinoma in the Era of Baveno VII

Session: KASL Symposium 4. Integrative Approaches to Alcohol-Related Hepatic Disorders [Chairperson]

Augusto VillanuevaIcahn School of Medicine at Mount Sinai, USA

Session: TLW Special Interest Group. Integrating Multi-Omics for Precision Oncology

Lecture: Integration of Clinical, Computational, and Genomic Resources for Early HCC Detection

Session: KLCA Symposium 3. Revisiting and Expanding Hepatocellular Carcinoma Treatment Paradigms: From Standard to Innovative Therapies [Chairperson]

Takehisa WatanabeKumamoto Univ., Japan

Session: KASL Special Interest Group 4. The KASL Viral Hepatitis Study Group

Lecture: A Novel Anti-HBV Compound Reduces HBsAg and HBV-DNA by Destabilizing HBV-RNA

Tomoharu YamadaThe Univ. of Tokyo., Japan

Session: KLCA-JLCA Joint Symposium. Optimizing Bridging Gaps in Pre- and Post-Liver Transplantation for HCC

Lecture: Innovative Bridging Therapies for HCC: From Transarterial Chemoembolization to Immune Checkpoint Inhibitors

Tomoharu YoshizumiKyushu Univ., Japan

Session: KLCA-JLCA Joint Symposium. Optimizing Bridging Gaps in Pre- and Post-Liver Transplantation for HCC

Lecture: Immunosuppression and Immunotherapy in Post-Liver Transplant HCC: Striking the Right Balance

Ming-Chin YuChang Gung Univ., Taiwan

Session: KLCA-TLCA Joint Symposium. Innovating and Expanding Surgical Horizons for HCC in the Immunotherapy Era

Lecture: Advancing Liver Surgery in the Immunotherapy Era: The Taiwanese Experience